
CEO

Hayley French PhD
CEO
Dr. Hayley French is an accomplished commercial leader and qualified attorney with over 25 years’ experience across the life science industry. Prior to joining Domainex, Hayley was Chief Executive Officer of Apitope Technology NV which was acquired by Worg Pharmaceuticals in September 2021. Before joining Apitope, Hayley spent three years at Novartis, based at the Basel headquarters, where she worked closely on all global deals and collaborations in the respiratory division.
She has also worked in the Life Sciences Group of Bird & Bird, London, specialising in advising pharmaceutical and biotech companies and as Head of Commercial Legal Affairs at the Centre for Applied Microbiology and Research (CAMR) in Salisbury, UK.
Hayley started her career at University College London Ventures where she was responsible for the development, management and commercialisation of technologies in the life sciences sector. She is past president of the Licensing Executives Society Britain & Ireland, and a past board member of Licensing Executives Society International (LESI).
Hayley has a B.Sc. in Microbiology from the University of Liverpool, as well as a PhD in Microbiology and a M.Sc. in intellectual property from the University of London and is a certified licensing professional (CLP).
Hayley is also a venture partner for Vesalius Biocapital and chair of Octiocor Limited.